This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Vanderbilt University. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Emilianne M Limbrick: Innovator in Biosynthesis
Introduction
Emilianne M Limbrick is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of biosynthesis, particularly in the development of everninomicin analogs. With a total of 2 patents, her work is paving the way for advancements in treating infections.
Latest Patents
Limbrick's latest patents focus on the biosynthesis of everninomicin analogs. The disclosed methods involve genetic alteration to prepare these analogs. Additionally, the patents detail the use of these everninomicin analogs in treating infections, showcasing her innovative approach to addressing medical challenges.
Career Highlights
Emilianne M Limbrick is affiliated with Vanderbilt University, where she continues her research and development efforts. Her work is characterized by a commitment to advancing scientific knowledge and improving healthcare outcomes.
Collaborations
Limbrick collaborates with esteemed colleagues, including Kasia Derewacz and Brian O Bachmann. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Emilianne M Limbrick is a trailblazer in the field of biosynthesis, with her innovative patents and collaborations driving progress in medical treatments. Her contributions are vital to the ongoing development of effective therapies for infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile